Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07169409 · ClinicalTrials.gov registry record · Phase 1
Right Tools, Right Time, Right Place: Telehealth for Opioid Use Disorder in Vulnerable Settings
A Phase 1 study of Opioid Use Disorder, sponsored by Boulder Care.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT07169409: Recruiting Phase 1 study of Opioid Use Disorder, sponsored by Boulder Care.
NCT07169409 is a Phase 1 study of Opioid Use Disorder that is actively recruiting participants, run by Boulder Care. The registered enrollment target is 250 participants, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07169409, a Phase 1 study of Opioid Use Disorder, is actively recruiting participants, sponsored by Boulder Care.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
Our primary objective is to evaluate the ability of Boulder Care's telehealth-platform to create the necessary paradigmatic shift in Opioid Use Disorder (OUD) treatment to reach vulnerable populations, with targets that support both equitable and culturally-specific OUD treatment as well as business profitability.
Primary Outcome
To measure the participant intervention experience, the study team will utilize qualitative interview data with study participants. These data will be organized into the implementation science categories: Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM). The study team will determine whether each participant found the intervention to be feasible, acceptable, and/or appropriate. These findings will then be aggr
Conditions Studied
Interventions
- DRUG Telemedicine Buprenorphine Treatment
Study Locations (1)
Oregon
- Boulder Care - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2025-06-10 |
| Est. Completion | 2027-09-15 |
| Phase | Phase 1 |
What NCT07169409 shows while recruiting
NCT07169409 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Telemedicine Buprenorphine Treatment is the first listed.
NCT07169409 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT07169409 about?
NCT07169409 is a clinical study titled "Right Tools, Right Time, Right Place: Telehealth for Opioid Use Disorder in Vulnerable Settings". Our primary objective is to evaluate the ability of Boulder Care's telehealth-platform to create the necessary paradigmatic shift in Opioid Use Disorder (OUD) treatment to reach vulnerable populations, with targets that support both equitable and culturally-specific OUD treatment as well as business...
What is the current status of trial NCT07169409?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 250 participants. The study started on 2025-06-10. Estimated completion is 2027-09-15.
What conditions does trial NCT07169409 study?
This clinical trial studies the following conditions: Opioid Use Disorder.
What interventions are being tested in trial NCT07169409?
The interventions under investigation include: Telemedicine Buprenorphine Treatment (DRUG).
Who is sponsoring clinical trial NCT07169409?
This trial is sponsored by Boulder Care, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07169409 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07169409's enrollment target sits among peer trials
250 70th of 257 higher than 185 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder
RECRUITING · Phase 1
-
Cannabis and Opioid Use Disorder
RECRUITING · Phase 1
-
Adjunctive Effects of Psilocybin and a Formulation of Buprenorphine
RECRUITING · Phase 1
-
A Bundled Intervention
RECRUITING · Phase 1
-
Evaluation of the Interactions of Cannabidiol (CBD) With Morphine
RECRUITING · Phase 1
-
Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI